SAS programming is essential for transforming, analyzing, and reporting clinical trial data. It enables accurate statistical analysis, supports regulatory compliance, and helps in deriving conclusions about the safety and efficacy of new drugs.
Our SAS programmers follow CDISC standards, including SDTM and ADaM, and produce audit-ready outputs that meet FDA, EMA, and PMDA expectations. We also generate well-documented, traceable code and datasets to support transparency and reproducibility.
Yes. We leverage SAS’s cloud capabilities to provide scalable analytics, offering real-time insights, faster processing, and seamless collaboration across global clinical teams.
Absolutely. We create integrated environments by connecting SAS outputs with clinical data management, EDC systems, and other analytics platforms—helping clients manage and visualize data from a unified interface.
While we primarily serve pharmaceutical and biotechnology companies, our SAS programming solutions are also valuable to CROs, medical device manufacturers, research institutions, and academic clinical research centers
